David A. Rosa

CIK: 0001540354

Transaction Breakdown

Open Market Buys (P)1 (5.9%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (17.6%)

Compensation grants

Other (G, F, J, C, D, …)13 (76.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

NMTC

NEUROONE MEDICAL TECHNOLOGIES Corp

DirectorOfficer

BRTX

BioRestorative Therapies, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (17 total)

NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Aug 28, 2026
Award(A)
Option to Purchase Common Stock
Direct
68K shares-
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Mar 31, 2026
Tax Payment(F)
Direct
2.5K shares at avg. $0.78$2K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Feb 18, 2026
Tax Payment(F)
Direct
71.3K shares at avg. $0.68$49K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Dec 31, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $0.76$2K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Sep 30, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $0.89$2K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Jun 30, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $0.68$2K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Apr 17, 2025
Award(A)
Option to Purchase Common Stock
Direct
750K shares-
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Apr 4, 2025
Purchase(P)
Direct
100K shares at avg. $0.50$50K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Mar 31, 2025
Tax Payment(F)
Direct
2.5K shares at avg. $0.85$2K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Feb 18, 2025
Tax Payment(F)
Direct
71.3K shares at avg. $1.16$83K
BRTX
BioRestorative Therapies, Inc.
Feb 14, 2025
Award(A)
Stock Option
Direct
52.6K shares-
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Jan 31, 2025
Tax Payment(F)
Direct
2.2K shares at avg. $1.15$3K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Dec 31, 2024
Tax Payment(F)
Direct
4.7K shares at avg. $0.83$4K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Nov 30, 2024
Tax Payment(F)
Direct
2.2K shares at avg. $0.62$1K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Oct 31, 2024
Tax Payment(F)
Direct
2.2K shares at avg. $0.97$2K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Sep 30, 2024
Tax Payment(F)
Direct
4.7K shares at avg. $0.99$5K
NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp
Aug 31, 2024
Tax Payment(F)
Direct
2.2K shares at avg. $0.80$2K

		Type	Shares	Price		Ownership
Aug 28, 2026	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Award(A) Option to Purchase Common Stock	68,000	-	-	Direct
Mar 31, 2026	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,458	$0.78	$1,910	Direct
Feb 18, 2026	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	71,325	$0.68	$48,501	Direct
Dec 31, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,458	$0.76	$1,863	Direct
Sep 30, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,458	$0.89	$2,184	Direct
Jun 30, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,458	$0.68	$1,667	Direct
Apr 17, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Award(A) Option to Purchase Common Stock	750,000	-	-	Direct
Apr 4, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Purchase(P)	100,000	$0.50	$50,000	Direct
Mar 31, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,458	$0.85	$2,090	Direct
Feb 18, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	71,325	$1.16	$82,737	Direct
Feb 14, 2025	BRTX BioRestorative Therapies, Inc.	Award(A) Stock Option	52,632	-	-	Direct
Jan 31, 2025	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,239	$1.15	$2,575	Direct
Dec 31, 2024	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	4,697	$0.83	$3,880	Direct
Nov 30, 2024	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,239	$0.62	$1,395	Direct
Oct 31, 2024	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,239	$0.97	$2,172	Direct
Sep 30, 2024	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	4,697	$0.99	$4,650	Direct
Aug 31, 2024	NMTC NEUROONE MEDICAL TECHNOLOGIES Corp	Tax Payment(F)	2,239	$0.80	$1,783	Direct

1-17 of 17 transactions

About Rosa David A

Rosa David A (SEC CIK 0001540354) files insider reports with the SEC as CEO & President of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) and Director of BioRestorative Therapies, Inc. (BRTX).

Signal8 holds 17 ownership filings by Rosa David A, all Form 4s, filed between Sep 4, 2024 and Aug 28, 2026. Those filings report 17 transactions, from Aug 31, 2024 to Aug 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rosa David A's filings is in EDEN PRAIRIE, MN.

Recent filings by Rosa David A

Aug 28, 2026: Grant or award of NMTC derivative securities (Form 4, code A).
Mar 31, 2026: Tax withholding of NMTC shares (Form 4, code F).
Feb 18, 2026: Tax withholding of NMTC shares (Form 4, code F).
Dec 31, 2025: Tax withholding of NMTC shares (Form 4, code F).
Sep 30, 2025: Tax withholding of NMTC shares (Form 4, code F).

Other insiders filing for NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

Wambeke David J., Chief Business Officer
Johns Emily J., Chief Administrative Officer
Volker Christopher, Chief Financial Officer
Christianson Mark, Market Development Director
Mertens Steve, Chief Technology Officer
Pratt Brian, 10% Owner

How to read Form 4 transaction codes